➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Colorcon
Express Scripts
Harvard Business School
Merck

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Litigation Details for Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc. (D. Nev. 2016)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc. (D. Nev. 2016)

Docket   Start Trial Date Filed 2016-10-31
Court District Court, D. Nevada Date Terminated 2020-03-30
Cause 35:271 Patent Infringement Assigned To Miranda Mai Du
Jury Demand None Referred To Nancy J. Koppe
Parties AMARIN PHARMA, INC.; AMARIN PHARMACEUTICALS IRELAND LIMITED; DR. REDDY'S LABORATORIES, INC.; DR. REDDY'S LABORATORIES, LTD.; HIKMA PHARMACEUTICALS USA INC.; TEVA PHARMACEUTICAL INDUSTRIES LIMITED; TEVA PHARMACEUTICALS USA, INC.; WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED
Patents 10,010,083; 10,016,338; 10,016,403; 10,029,011; 10,029,015; 10,030,051; 10,046,000; 10,046,031; 10,046,056; 10,046,058; 10,047,033; 10,086,005; 10,092,009; 10,114,012; 10,155,002; 10,183,004; 10,183,020; 10,232,003; 10,232,004; 10,232,015; 10,278,936; 10,300,010; 10,611,989; 6,359,016; 6,720,001; 6,737,006; 6,867,005; 6,869,952; 7,022,014; 7,022,713; 7,141,018; 7,173,016; 7,301,023; 7,619,004; 7,728,010; 8,003,096; 8,008,003; 8,013,002; 8,022,106; 8,039,009; 8,039,010; 8,039,030; 8,044,014; 8,044,046; 8,048,017; 8,048,035; 8,048,043; 8,058,052; 8,114,021; 8,293,727; 8,293,728; 8,318,715; 8,344,011; 8,357,677; 8,367,652; 8,377,920; 8,395,021; 8,399,446; 8,415,335; 8,426,399; 8,431,560; 8,435,752; 8,436,010; 8,440,650; 8,445,013; 8,445,018; 8,518,929; 8,524,698; 8,546,372; 8,569,021; 8,617,594; 8,642,012; 8,699,019; 8,748,379; 8,829,013; 8,852,889; 8,952,015; 8,993,017; 9,000,002; 9,000,021; 9,005,016; 9,005,056; 9,018,017; 9,020,056; 9,022,022; 9,023,001; 9,024,007; 9,028,005; 9,035,031; 9,035,033; 9,040,034; 9,040,039; 9,040,049; 9,056,051; 9,056,052; 9,056,057; 9,056,059; 9,061,005; 9,127,013; 9,132,003; 9,194,011; 9,297,013; 9,352,016; 9,415,004; 9,415,009; 9,694,015; 9,981,025
Attorneys Adam Hosmer-Henner; Alaina Marie Whitt; Alan Clement; Alison Michelle Heydorn; Beth Finkelstein; Brian R. Irvine; Caroline Sun; Chandrika Vira; Charles B. Klein; Chelsea Latino; Christopher Neil Sipes; Claire A Fundakowski; Constance S. Huttner; Daniel Joseph Farnoly; Dmitry Shelhoff; Eimeric Reig-Plessis; Einar Stole; Eric Ritland Sonnenschein; Frank D Rodriguez; George Carter Lombardi; Han Park; James Barabas; Jason D Smith; Jeffrey Elikan; Jennifer Marie Coronel; John Patrick Desmond; John Rozendaal; Jonathan W Fountain; Jordan Laird Moran; Justin James Bustos; Maria M Mercera; Megan Patricia Keane; Michael D Rounds; Michael Joffre; Michael Kennedy; Myoka Kim Goodin; Nicholas J Santoro; Nina Vachhani; Ryan James Cudnik; W. West Allen; Wayne A Shaffer
Firms Brownstein Hyatt Farber Schreck, LLC; Brownstein Hyatt Farber Schreck, LLP; Budd Larner PC; Covington & Buling LLP; Covington & Burling LLP; Covington & Burling, LLP; Covington and Burling LLP; Dickinson Wright; Dickinson Wright PLLC; Eimeric Reig-Plessis; Howard & Howard Attorneys, PLLC; Laxalt & Nomura Ltd; Locke Lord LLP; McDonald Carano LLP; McDonald Carano Wilson LLP; One CityCenter; Pisanelli Bice, PLLC; Santoro Whitmire; Sterne Kessler Golstein & Fox, PLLC; Sterne, Kessler, Goldstein & Fox Pllc; Windels Marx Lane & Mittendorf, LLP; Windels, Marx, Lane & Mittendorf, LLP; Winston & Strawn; Winston & Strawn LLP
Link to Docket External link to docket
Biologic Drugs cited in Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc. (D. Nev. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-10-31 1 Complaint U.S. Patent No. 8,293,728 (“the ‘728 Patent”), U.S. Patent No. 8,318,715 (“the 7 ‘715 Patent”), U.…above. 2 33. United States Patent No. 8,293,728, entitled “METHODS OF TREATING 3 HYPERTRIGLYCERIDEMIA… Patent, the ‘335 Patent, the ‘399 Patent, 12 the ‘560 Patent, the ‘650 Patent, the ‘929 Patent, the…of the ‘728 Patent, the ‘715 Patent, the 11 ‘677 Patent, the ‘652 Patent, the ‘920 Patent, the ‘446 Patent…U.S. Patent No. 8,357,677 (“the ‘677 Patent”), U.S. Patent No. 8,367,652 (“the 8 ‘652 Patent”), U.S External link to document
2018-08-10 135 Order but is discussed. It is U.S. Patent No. 8,293,727 (“the ‘727 28 patent”). …the ‘715 patent”); (3) U.S. Patent No. 8,357,677 (“the ‘677 9 patent”); (4) U.S. Patent No. 8,367,652…“the ‘652 patent”); (5) U.S. Patent No. 10 8,377,920 (“the ‘920 patent”); (6) U.S. Patent No. 8,399,446…“the ‘446 patent”); (7) U.S. 11 Patent No. 8,415,335 (“the ‘335 patent”); (8) U.S. Patent No. 8,426,399… ‘399 12 patent”); (9) U.S. Patent No. 8,431,560 (“the ‘560 patent”); (10) U.S. Patent No. 13 8, External link to document
2019-01-03 174 Order on Verified Petition for Permission to Practice Pro Hac Vice 8 ' 9 …2016 30 March 2020 2:16-cv-02525 830 Patent None District Court, D. Nevada External link to document
2019-08-09 236 Motion for Summary Judgment week.” See, e.g., Ex. 5, U.S. Patent No. 8,293,728 (“the ’728 patent”) at 3:65-4:7.1 These 11 undisputed… Ex. 6, U.S. Patent No. 8,318,715 (“the ’715 patent”), Claim 14; Ex. 7, U.S. Patent No. 8,357,677…the ’677 patent”), Claims 1, 7, and 8; Ex. 8, U.S. 19 Patent No. 8,367,652 (“the ’652 patent”), Claims…, U.S. Patent No. 8,431,560 (“the ’560 patent”), Claims 4, 7, and 17; Ex. 10, U.S. Patent No. 8,518,929…noninfringement as to all 15 asserted patent 3 claims from six related patents that Amarin contends cover methods External link to document
2019-08-30 247 Response 728 pat. U.S. Patent No. 8,293,728 3 ’715 pat. U.S. Patent No. 8,318,715 4 ’…677 pat. U.S. Patent No. 8,357,677 5 ’652 pat. U.S. Patent No. 8,367,652 6 ’560… during prosecution of Amarin’s patent 6 applications, the Patent Office repeatedly found that the…comply with section 112 of the Patent Act, which mandates that a patent’s 9 “specification shall contain…render 15 the patents invalid as a matter of law. On their face, Amarin’s patents—which were filed External link to document
2019-08-30 252 Response OF ABBREVIATIONS 2 ’728 Patent U.S. Patent No. 8,293,728 (filed Jan. 12, 2012) (Defs… 16 of the '728 Patent 25 (Defs.' Ex. 5); Claim 14 ofthe '715 Patent (Defs.' Ex. 6);… the '677 Patent (Defs.' Ex. 7); Claims 1, 7, and 8 of the '652 Patent (Defs.' Ex…26 '560 Patent (Defs.' Ex. 9); an d Claims 1 and 5 of the '929 Patent (Defs.' Ex. …well beyond 12 weeks, and the patent specification (e.g., in the Patent Example), 14 describes treatment External link to document
2019-10-28 278 Order on Motion for Partial Summary Judgment and 16 of [U.S. Patent No. 21 8,293,728 (“the ’728 Patent”)], Claim 14 of [U.S. Patent No. 8,318,715…the ’715 patent”)], 22 Claims 1, 7, and 8 of U.S. Patent No. 8,357,677 (“the ’677 Patent”), Claims… 23 U.S. Patent No. 8,367,652 (“the ’652 Patent”), Claims 4, 7, and 17 of U.S. Patent No. 24 8,431,560…“the ’560 Patent”), and Claims 1 and 5 of U.S. Patent No. 8,518,929 (“the ’929 25 Patent”).” (ECF …infringement of Bayer’s patent 4 with a hypothetical different case where “[t]he patent does not claim a External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Dow
McKinsey
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.